Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect.
Prasit KK, Ferrer-Font L, Burn OK, Anderson RJ, Compton BJ, Schmidt AJ, Mayer JU, Chen CJ, Dasyam N, Ritchie DS, Godfrey DI, Mattarollo SR, Dundar PR, Painter GF, Hermans IF.
Prasit KK, et al. Among authors: dasyam n.
Oncoimmunology. 2022 Jun 13;11(1):2081009. doi: 10.1080/2162402X.2022.2081009. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35712122
Free PMC article.